RxDoctor Payments Data

Yan Wang

Dermatology · St Louis Park, MNNPI 1699752444

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,770, more than ten times the $135 reported in 2019. Among dermatology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,007in general payments, 2019–2025

Across 219 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$685
  • Incyte Corporation$581
  • Regeneron Healthcare Solutions, Inc.$555
  • AbbVie$450
  • LEO Pharma Inc.$409
  • Johnson & Johnson$379
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,79796%
  • Education$2104%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,007 in reported general payments places this provider in the 90th percentile of 273 dermatology providers in Minnesota.

See all dermatology providers in Minnesota

Medicare billing

Part B allowed, 2024
$148,671
Medicare patients
312
Services billed
2,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab20$84,348
AdbryTralokinumab-Ldrm14$57,104
Fluorouracil69$5,994
Clobetasol Propionate67$4,861
Fluocinonide26$1,186
Imiquimod22$971
CiclopiroxCiclopirox Olamine23$808
Ketoconazole47$737
Econazole Nitrate17$608
Alclometasone Dipropionate14$430
Triamcinolone Acetonide37$408
Minoxidil39$317
Doxycycline Monohydrate12$241
Mupirocin17$199
Cephalexin17$118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
LEO Pharma Inc.Adbry$409$57,10414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 273 dermatology providers in Minnesota.

Other dermatology in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →